Nuevos medicamentos con aplicación en dermatología
Keywords:
inmunomoduladores, autoinmune, apoptosisAbstract
En el tratamiento de las enfermedades cada día se abren nuevas posibilidades, con la aparición de agentes que tienen alta efectividad y selectividad, con menos efectos adversos.
Este artículo sólo pretende recordar algunos de ellos, unos disponibles en el mercado, otros no, y muchos más aún en etapa de investigación.
Author Biography
Nancy Castro Salgado, Fundación Santafé
Dermatóloga Sección de Dermatología, Fundación Santafé de Bogotá, Bogotá, Colombia.
References
1. Ruzicka T, Bieber T, Schoff E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997; 337:816-821.
https://doi.org/10.1056/NEJM199709183371203
2. Nakagawa H, Eton T, lshibashi Y. Tacrolimus ointment for atopic dermatitis. Lancet 1994; 344:883.
https://doi.org/10.1016/S0140-6736(94)92855-X
3. Alaiti S, Kang S, Fiedler Y, et al. Tacrolimus (FK-506) ointment for atopic dermatitis: A phase I study in adults and children. J Am Acad Dermatol 1998; 30:69-76.
https://doi.org/10.1016/S0190-9622(98)70541-9
4. Chu T J, Waren MS. Zafirlukast (accolate) in the treatment of chronic idiopathic urticaria. A case series. J Allerg lmmunol 1998; 101:S155, Abs. 641. Carruci JA, Washenik K, Weinstein A, et al. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998; 134:785-786.
https://doi.org/10.1001/archderm.134.7.785
6. López AL, López G, Orozco S, et al. Zafirlukast in case of severe eczema with hyper-lgE. Annal Allerg Asthma lmmunol 1999; 82:82.
7. Spector S. Antileukotrienes in chronic urticaria (letter). J Allerg lmmunol 1998; 101 :572.
https://doi.org/10.1016/S0091-6749(98)70374-4
8. Silverman-Kitchin J, Keltz PM, Pak G, et al. Rediscovering mycophenolic acid: A review o its mechanism, side effects and potential uses. J Am Acad Dermatol 1997; 37:445-449.
https://doi.org/10.1016/S0190-9622(97)70147-6
9. Gray DW. Mycophenolato Mofetil for transplantation: New drug old problems? Lancet 1996; 346-390.
https://doi.org/10.1016/S0140-6736(95)92775-1
10. Lipsky JJ. Mycophenolato mofetil. Lancet 1996: 348: 1357-1359.
https://doi.org/10.1016/S0140-6736(96)10310-X
11. Weinstein GD et al. Tazarotene gel, a new retinoid for topical therapy of psoriasis: vehicle controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997; 37:82-85.
https://doi.org/10.1016/S0190-9622(97)70216-0
12. Chandraratna RAS. Tazarotene: First a new generation of receptor selective retinoid. Br J Dermatol 1996; 135:18-25.
https://doi.org/10.1111/j.1365-2133.1996.tb15662.x
13. Roshantha AS et al. Tazarotene. The first receptor selective topical retioid for treatment of psoriasis. J Am Acad Dermatol 1997; 37:S12-17.
https://doi.org/10.1016/S0190-9622(97)70411-0
https://doi.org/10.1056/NEJM199709183371203
2. Nakagawa H, Eton T, lshibashi Y. Tacrolimus ointment for atopic dermatitis. Lancet 1994; 344:883.
https://doi.org/10.1016/S0140-6736(94)92855-X
3. Alaiti S, Kang S, Fiedler Y, et al. Tacrolimus (FK-506) ointment for atopic dermatitis: A phase I study in adults and children. J Am Acad Dermatol 1998; 30:69-76.
https://doi.org/10.1016/S0190-9622(98)70541-9
4. Chu T J, Waren MS. Zafirlukast (accolate) in the treatment of chronic idiopathic urticaria. A case series. J Allerg lmmunol 1998; 101:S155, Abs. 641. Carruci JA, Washenik K, Weinstein A, et al. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998; 134:785-786.
https://doi.org/10.1001/archderm.134.7.785
6. López AL, López G, Orozco S, et al. Zafirlukast in case of severe eczema with hyper-lgE. Annal Allerg Asthma lmmunol 1999; 82:82.
7. Spector S. Antileukotrienes in chronic urticaria (letter). J Allerg lmmunol 1998; 101 :572.
https://doi.org/10.1016/S0091-6749(98)70374-4
8. Silverman-Kitchin J, Keltz PM, Pak G, et al. Rediscovering mycophenolic acid: A review o its mechanism, side effects and potential uses. J Am Acad Dermatol 1997; 37:445-449.
https://doi.org/10.1016/S0190-9622(97)70147-6
9. Gray DW. Mycophenolato Mofetil for transplantation: New drug old problems? Lancet 1996; 346-390.
https://doi.org/10.1016/S0140-6736(95)92775-1
10. Lipsky JJ. Mycophenolato mofetil. Lancet 1996: 348: 1357-1359.
https://doi.org/10.1016/S0140-6736(96)10310-X
11. Weinstein GD et al. Tazarotene gel, a new retinoid for topical therapy of psoriasis: vehicle controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997; 37:82-85.
https://doi.org/10.1016/S0190-9622(97)70216-0
12. Chandraratna RAS. Tazarotene: First a new generation of receptor selective retinoid. Br J Dermatol 1996; 135:18-25.
https://doi.org/10.1111/j.1365-2133.1996.tb15662.x
13. Roshantha AS et al. Tazarotene. The first receptor selective topical retioid for treatment of psoriasis. J Am Acad Dermatol 1997; 37:S12-17.
https://doi.org/10.1016/S0190-9622(97)70411-0
How to Cite
1.
Castro Salgado N. Nuevos medicamentos con aplicación en dermatología. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2001 Jul. 1 [cited 2024 Jul. 3];9(2):521-4. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/829
Downloads
Download data is not yet available.
Downloads
Published
2001-07-01
How to Cite
1.
Castro Salgado N. Nuevos medicamentos con aplicación en dermatología. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2001 Jul. 1 [cited 2024 Jul. 3];9(2):521-4. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/829
Issue
Section
Terapéutica
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
